APOLLO HOSPITALS ENTER. L vs Parenteral Drugs (India) Ltd
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and Parenteral Drugs (India) Ltd (PDPL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs PDPL on 10 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
- − ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
- + ["Company has reduced debt."]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -48.3% over past five years.", "Contingent liabilities of Rs.135 Cr.", "Company's cost of borrowing seems high"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.